Extreme Short Interest in MIRA
Data from AltIndex as of September 3, 2026, identifies Mira Pharmaceuticals (MIRA) as a top-tier short squeeze candidate. With a staggering 56.6% of its float held short, the stock is currently categorized under an 'Extreme' short signal. This level of bearish positioning suggests that any positive catalyst could trigger a rapid covering rally, forcing short sellers to buy back shares at higher prices.
Market Dynamics
Trading at approximately $0.85, MIRA has become a focal point for traders monitoring high-volatility setups. The combination of a low share price and massive short interest creates a classic squeeze environment. Investors should monitor for sudden spikes in volume, which often precede the forced liquidation of short positions in such highly-shorted names.
Key Takeaways
- Short Interest: 56.6% of float.
- Signal Status: Extreme short squeeze potential.
- Current Price: $0.85.
- Risk Profile: High volatility expected due to concentrated short positions.
The Bottom Line
MIRA represents one of the most aggressively shorted equities in the current market, making it a primary candidate for a violent short squeeze if momentum shifts.
Signal data sourced from AltIndex. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.